Cantoni
Leiden, NL · 9 employees on LinkedIn · 1 known investors
Cantoni Therapeutics develops small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) for the treatment of metabolic and oncology diseases. The company is a discovery and preclinical stage biotech enterprise based in the Netherlands.
Founders & leadership
Investors · 1
In the news
Frequently asked questions
- What does Cantoni do?
- Cantoni Therapeutics develops small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) for the treatment of metabolic and oncology diseases. The company is a discovery and preclinical stage biotech enterprise based in the Netherlands.
- Who founded Cantoni?
- Cantoni was founded by Matthijs van Haren, Nathaniel Martin.
- Who are Cantoni's investors?
- Cantoni's investors include BOM.
- Where is Cantoni headquartered?
- Cantoni is headquartered in Leiden, NL.